CAPA - What does the FDA expect from Medical Devices Manufacturers?
Recommendation
28/29 May 2024
Copenhagen, Denmark
Supervision of the Pharmaceutical Quality System: Challenges and Opportunities
Deficiencies with regard to CAPA (Corrective and Preventive Action) are regularly Top 1 in FDA's Warning Letter statistics (see our GMP News from 23 September 2014). The FDA has just recently published presentations in form of webinars on the following topics:
- Investigational Device Exemption (IDE) Program
- 510(k) Program
- Corrective and Preventive Actions (CAPA)
- Electronic Medical Device Reporting (eMDR)
The 31 slides on CAPA are particularly interesting and aim to:
- Explain the objective of CAPA
- Differentiate individual terms like Correction, Corrective Action, Preventive Action
- Clarify the requirements from the Quality System Regulations 21 CFR 820 (GMP for Medical Devices)
- Present diverse "Tools"
and
- Show examples and "Best Practices"
There is even the possibility to have a look at the webinar's slides "Corrective and Preventive Action Basics".
Related GMP News
18.01.2024Notified Body Survey on Certificates and Applications under the Medical Devices/IVD Regulation
18.01.2024Update of the EMA Q&A document on Combination Products
18.01.2024MDCG Guidance on the Responsible Person according to Article 15 MDR Updated
07.11.2023Harmonisation Efforts of the CDRH
07.11.2023Medical Devices Warning Letter Statistics for Fiscal Year 2023
07.11.2023FDA Publishes Lists of Planned Medical Device Guidances for Fiscal Year 2024